BRIEF REPORT Limitations of Rb-82 weight-adjusted dosing accuracy at low doses a b Jonathan B. Moody, PhD, Kerri M. Hiller, BS, CNMT, RT(N), a b a,b Benjamin C. Lee, PhD, James R. Corbett, MD, Edward P. Ficaro, PhD, and Venkatesh L. Murthy, MD, PhD INVIA Medical Imaging Solutions, Ann Arbor, MI Division of Nuclear Medicine, Department of Radiology, University of Michigan, Ann Arbor, MI Received Dec 18, 2015; accepted Apr 28, 2016 doi:10.1007/s12350-016-0531-2 Introduction. Weight-adjusted dosing is important to maintain accurate quantiﬁcation for dynamic cardiac three-dimensional positron emission tomography (PET). However, the man- ufacturer of the only Food and Drug Administration approved rubidium-82 (Rb-82) generator (CardioGen-82, Bracco Diagnostics, Inc.) recommends recalibration after each change in dose which is inefﬁcient in a busy clinical PET lab. The objective of this study was to evaluate the accuracy of Rb-82 dosing without this recalibration. Methods. After daily calibration to either 30 mCi (1110 MBq) or 12 mCi (444 MBq), Rb- 82 doses between 6 and 45 mCi (222-1665 MBq) were eluted and measured on an external dose calibrator. This was repeated for four generators at weeks 1, 2, or 4 of the generator cycle. The measurements were compared with values reported by
Journal of Nuclear Cardiology – Springer Journals
Published: May 16, 2016
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera